GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SD Biosensor Inc (XKRX:137310) » Definitions » Net Income From Continuing Operations

SD Biosensor (XKRX:137310) Net Income From Continuing Operations : ₩-256,651 Mil (TTM As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is SD Biosensor Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. SD Biosensor's net income from continuing operations for the three months ended in Mar. 2024 was ₩-11,165 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-256,651 Mil.


SD Biosensor Net Income From Continuing Operations Historical Data

The historical data trend for SD Biosensor's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SD Biosensor Net Income From Continuing Operations Chart

SD Biosensor Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Net Income From Continuing Operations
3,131.10 621,613.86 1,088,124.45 908,788.68 -467,904.10

SD Biosensor Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Income From Continuing Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -222,418.69 -83,060.00 -63,809.30 -98,616.11 -11,165.36

SD Biosensor Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-256,651 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SD Biosensor (XKRX:137310) Business Description

Traded in Other Exchanges
N/A
Address
16, Deogyeong-daero 1556 beon-gil, C-4&5Floor, Yeongtong-gu, Gyeonggi-do, Suwon-si, KOR, 16690
SD Biosensor Inc is an in vitro diagnostic company. It aims to contribute to the improvement of quality of life through rapid and accurate disease diagnosis. It is researching and developing quick diagnostics, immunodiagnostics, molecular diagnostics, blood glucose monitoring systems for self -testing.

SD Biosensor (XKRX:137310) Headlines

No Headlines